#1 Clinical Trials Search in Europe

Clodronate Disodium

This article examines the use of Clodronate Disodium, a bisphosphonate drug, in various clinical trials. These studies aim to evaluate its effectiveness in treating conditions such as breast cancer, osteoporosis, knee osteoarthritis, and preventing aseptic implant loosening after hip replacement surgery. The trials explore different dosages, administration methods, and compare Clodronate to other treatments to determine its efficacy and safety profile.

Table of Contents

What is Clodronate?

Clodronate disodium, also known by brand names such as Bonefos, is a medication that belongs to a class of drugs called bisphosphonates[1]. Bisphosphonates are medications that help prevent the breakdown of bones. Clodronate works by reducing the activity of cells called osteoclasts, which are responsible for breaking down bone tissue[1].

Uses of Clodronate

Clodronate is used to treat several conditions related to bone health:

  • Postmenopausal Osteoporosis: This is a condition where bones become weak and fragile after menopause, increasing the risk of fractures[1].
  • Bone Metastases: These are cancerous tumors that have spread from their original site to the bones. Clodronate is used in patients with bone metastases from breast cancer, prostate cancer, and multiple myeloma (a type of blood cancer that affects bone marrow)[2].
  • Pain Management: Clodronate has been associated with improvements in back pain in patients with osteoporosis and can help reduce pain in patients with bone metastases[1][3].

How Clodronate is Administered

Clodronate can be administered in several ways:

  • Oral tablets: Taken daily for extended periods, often for several months or years[2].
  • Intramuscular injections: Given into a muscle, typically every 1-2 weeks[1].
  • Intravenous infusions: Administered directly into a vein, though this is less common than oral or intramuscular routes[1].

The specific dosage and administration method will depend on the condition being treated and the patient’s individual needs. It’s important to follow your doctor’s instructions carefully when taking clodronate.

Effectiveness of Clodronate

Research has shown that clodronate can be effective in several ways:

  • Preventing bone loss: Clodronate helps maintain bone density, which is particularly important in postmenopausal women with osteoporosis[1].
  • Reducing fracture risk: By strengthening bones, clodronate can help reduce the risk of fractures in people with osteoporosis[1].
  • Pain relief: Many patients experience a reduction in bone pain when taking clodronate, particularly those with bone metastases[3].
  • Preventing skeletal-related events: In cancer patients with bone metastases, clodronate may help prevent complications such as fractures or the need for radiation therapy to the bones[2].

Potential Side Effects

While clodronate is generally well-tolerated, it can cause some side effects. These may include:

  • Gastrointestinal issues: Such as nausea, diarrhea, or stomach discomfort. These are more common with oral forms of the medication[1].
  • Flu-like symptoms: Some patients may experience fever, chills, or muscle aches, particularly after the first dose.
  • Injection site reactions: For intramuscular injections, there may be some pain or irritation at the injection site[1].

It’s important to discuss any side effects with your healthcare provider. They can help manage these effects or adjust your treatment if necessary.

Ongoing Research

Researchers continue to study clodronate to better understand its effects and potential uses. Some areas of ongoing research include:

  • Optimal dosing: Studies are investigating different doses and administration schedules to find the most effective and convenient regimens for patients[1].
  • Use in cancer treatment: Researchers are studying whether clodronate can help prevent cancer from spreading to the bones in patients with early-stage breast cancer[4].
  • Combination with other treatments: Studies are looking at how clodronate works when combined with other cancer treatments like chemotherapy or hormonal therapy[4].
  • Long-term effects: Researchers are investigating the long-term benefits and potential risks of clodronate use[5].

As research continues, we may learn more about how to use clodronate most effectively to improve bone health and quality of life for patients with various bone-related conditions.

Condition Trial Description Administration Method Key Outcomes Measured
Breast Cancer Comparing Clodronate to other bisphosphonates in preventing metastases Oral, daily for 35 months Disease-free survival, overall survival, sites of recurrence
Postmenopausal Osteoporosis Comparing different dosing regimens of intramuscular Clodronate Intramuscular, every week or every other week Lumbar bone mineral density
Knee Osteoarthritis Testing different doses of intra-articular Clodronate Intra-articular injection, weekly for 4 weeks Pain reduction (VAS score), functional improvements
Hip Replacement Using Clodronate to improve implant fixation Local application during surgery Implant migration (MTPM), bone mineral density

FAQ

  • What conditions is Clodronate Disodium being tested for in clinical trials? Clodronate Disodium is being tested for various conditions including breast cancer, postmenopausal osteoporosis, knee osteoarthritis, and prevention of aseptic implant loosening after hip replacement surgery.
  • How is Clodronate Disodium administered in these trials? The administration methods vary depending on the trial. It can be given orally, intramuscularly, intravenously, or even applied locally during surgery. For example, in one trial it was administered as an intramuscular injection, while in another it was used as a rinsing solution during hip replacement surgery.
  • What are some of the potential benefits of Clodronate Disodium being studied? Potential benefits being studied include preventing bone metastases in breast cancer patients, improving bone mineral density in osteoporosis, reducing pain in knee osteoarthritis, and enhancing implant fixation after hip replacement surgery.
  • How long do these clinical trials typically last? The duration of the trials varies. Some last for several months, while others continue for several years. For instance, one breast cancer trial lasted for 3 years, while a hip replacement study had a 2-year follow-up period.
  • What are some of the outcomes being measured in these trials? Outcomes being measured include disease-free survival, overall survival, bone mineral density, pain reduction, implant migration, and adverse events. Some trials also look at quality of life measures and patient adherence to the treatment.

Ongoing Clinical Trials on Clodronate Disodium

  • Study on the Effects of Clodronate Disodium for Patients with Painful Knee Osteoarthritis

    Recruiting

    4 1
    Investigated drugs:
    Italy

  • Study on Treating Osteogenesis Imperfecta in Patients Using Teriparatide and Zoledronic Acid

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Ireland The Netherlands

Glossary

  • Clodronate Disodium: A type of bisphosphonate drug used to treat bone diseases and prevent bone loss. It works by slowing down bone breakdown in the body.
  • Osteoporosis: A condition where bones become weak and brittle, increasing the risk of fractures. It's often associated with aging and hormonal changes, especially in postmenopausal women.
  • Bone Mineral Density (BMD): A measurement of how much mineral matter per square centimeter of bones. It's used to diagnose osteoporosis and assess the risk of fractures.
  • Metastasis: The spread of cancer cells from the place where they first formed to another part of the body. In breast cancer, bone metastasis is a common concern.
  • Intramuscular (IM): A method of injecting medication directly into a muscle. Some trials use IM injections of Clodronate.
  • Intravenous (IV): Administration of medication directly into a vein. Some trials use IV administration of Clodronate.
  • Placebo: A substance with no active therapeutic effect, used as a control in testing new drugs. Some trials compare Clodronate to a placebo.
  • Radiostereometric Analysis (RSA): A highly accurate technique for measuring small movements in orthopedic implants, used in the hip replacement trial to assess implant migration.
  • Visual Analogue Scale (VAS): A measurement instrument for subjective characteristics or attitudes that cannot be directly measured, often used to assess pain levels in clinical trials.
  • Adverse Event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.

References

  1. https://clinicaltrials.gov/study/NCT01348243
  2. https://clinicaltrials.gov/study/NCT01198457
  3. https://clinicaltrials.gov/study/NCT00909142
  4. https://clinicaltrials.gov/study/NCT00009945
  5. https://clinicaltrials.gov/study/NCT00127205